BioSpace Movers & Shakers: Enveda, Evaxion, Elevation
Biopharma and life sciences companies continue to strengthen their executive teams and boards with this week’s Movers & Shakers.
Source: biospace.com
Page 9 - Quantum Genomics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Quantum Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Quantum Genomics Today - Breaking & Trending Today
Stéphane Cohen joins Quantum Genomics as Director of Global Operations Quantum Genomics , a biopharmaceutical company specializing in the development of a new drug class directly... | March 14, 2022
Source: marketscreener.com
Shunt Therapy Falters in HF Without Reduced EF: REDUCE LAP-HF 2
The trial was 'neutral' but said to have produced important mechanistic insights that could guide the investigational heart failure device therapy to success in the future.
Source: medscape.com
Heart Failure Drugs Market Size, Trends & Technological Innovation: Major Players Amgen Inc., AstraZ
DBMR added a new report titled Heart Failure Drugs Market with data tables for historical and forecast years represented by discussions and graphs spread over pages with easy to understand detailed analysis. The report provides the facts of all the drivers and constraints that are derived from the SWOT analysis. Thi...
Source: pharmiweb.com
QUANTUM GENOMICS: Quantum Genomics signs an exclusive license and production agreement with Gulf Pharmaceuticals Industries Julphar.
Press release Paris, December 6, 2021 Quantum Genomics signs an exclusive license and production agreement with Gulf Pharmaceuticals Industries Julphar. Quantum Genomics will receive up to $20 M
Source: finanznachrichten.de